GS-4321

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-4321, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus [Phase 1, Phase 2]